Baidu
map

NEJM:福氏耐格里阿米巴-病例报道

2020-09-10 MedSci原创 MedSci原创

聚合酶链反应测定法确定为福氏耐格里阿米巴。福氏耐格里阿米巴通常与夏季和淡水有关,可引起原发性阿米巴脑膜脑炎,尽管几乎没有存活病例。

患者为一名44岁的男子,因意识混乱和咳嗽1天而到急诊就诊。六天前,他曾在印度的室内游泳池里游泳。

就诊时,他的体温为39.8°C,心律为每分钟120次。他没有回答问题,对视觉威胁也没有眨眼。然而,脑干反射完好无损,他从痛苦的刺激中缩回了双臂和双腿。他没有颈部僵硬或皮疹。腰椎穿刺检查发现脓性积液(如图A所示),每立方毫米有2083个有核细胞(中性粒细胞为91%),葡萄糖水平为87 mg/dL(4.8 mmol/L)(参考范围为40至70mg/dL[2.2至3.9mmol/L],蛋白质水平为477 mg/dL(参考范围10至45mmol/L)。

该患者开始接受针对细菌性脑膜炎的经验性抗生素治疗;尽管发热有所减轻,但精神状况并未改善。使用Wright–Giemsa染色剂对脑脊髓液进行了检查,发现滋养体与阿米巴一致(如图B所示)。聚合酶链反应测定法确定为福氏耐格里阿米巴。福氏耐格里阿米巴通常与夏季和淡水有关,可引起原发性阿米巴脑膜脑炎,尽管几乎没有存活病例。

该患者尽管接受了两性霉素、利福平、氟康唑、阿奇霉素和米替福辛治疗,但在就诊后5天死亡。

原始出处:

Glenn R. Harris,et al.Naegleria fowleri.N Engl J Med 2020;https://www.nejm.org/doi/full/10.1056/NEJMicm2002528

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (12)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=887344, encodeId=e6ce88e344e6, content=谢谢分, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK0iclWFtP7WicKXLyVXAOnRibMria0BwB4otV2d2ibbbkZ2XKAvnNH5x3Y1wm9ibMNZZV5ib5qA0B99sMpw/132, createdBy=9a062530214, createdName=yelinlin, createdTime=Tue Sep 22 14:01:19 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886787, encodeId=65fb886e870e, content=非常好的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200911/86e05ece1f2c4d5ab7a4a35c0243a1f3/895d564b15c340ebb73be808a4e3de8f.jpg, createdBy=50935306414, createdName=医学生upup木子楠, createdTime=Sun Sep 20 08:58:12 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886785, encodeId=aee7886e8563, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200911/86e05ece1f2c4d5ab7a4a35c0243a1f3/895d564b15c340ebb73be808a4e3de8f.jpg, createdBy=50935306414, createdName=医学生upup木子楠, createdTime=Sun Sep 20 08:48:00 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884527, encodeId=0e2b88452ee7, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200911/86e05ece1f2c4d5ab7a4a35c0243a1f3/895d564b15c340ebb73be808a4e3de8f.jpg, createdBy=50935306414, createdName=医学生upup木子楠, createdTime=Fri Sep 11 13:27:06 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884526, encodeId=9c8e884526f6, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200911/86e05ece1f2c4d5ab7a4a35c0243a1f3/895d564b15c340ebb73be808a4e3de8f.jpg, createdBy=50935306414, createdName=医学生upup木子楠, createdTime=Fri Sep 11 13:26:34 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884410, encodeId=260f884410c8, content=学习。, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7572458878, createdName=12412355m93暂无昵称, createdTime=Fri Sep 11 05:36:23 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884367, encodeId=6cd688436e1f, content=继续与病魔抗争,希望有胜利的一天。, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Thu Sep 10 22:56:15 CST 2020, time=2020-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884249, encodeId=188688424982, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/a59b28b63198490ea85b1e5b3d13c2bf/1b1e0d03ca22467d8120443ebbc24c04.jpg, createdBy=35d22207591, createdName=120cac51m28暂无昵称, createdTime=Thu Sep 10 16:09:47 CST 2020, time=2020-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884248, encodeId=f63b884248a0, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/a59b28b63198490ea85b1e5b3d13c2bf/1b1e0d03ca22467d8120443ebbc24c04.jpg, createdBy=35d22207591, createdName=120cac51m28暂无昵称, createdTime=Thu Sep 10 15:55:50 CST 2020, time=2020-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035412, encodeId=602a1035412c5, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Sep 10 15:11:42 CST 2020, time=2020-09-10, status=1, ipAttribution=)]
    2020-09-22 yelinlin

    谢谢分

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=887344, encodeId=e6ce88e344e6, content=谢谢分, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK0iclWFtP7WicKXLyVXAOnRibMria0BwB4otV2d2ibbbkZ2XKAvnNH5x3Y1wm9ibMNZZV5ib5qA0B99sMpw/132, createdBy=9a062530214, createdName=yelinlin, createdTime=Tue Sep 22 14:01:19 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886787, encodeId=65fb886e870e, content=非常好的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200911/86e05ece1f2c4d5ab7a4a35c0243a1f3/895d564b15c340ebb73be808a4e3de8f.jpg, createdBy=50935306414, createdName=医学生upup木子楠, createdTime=Sun Sep 20 08:58:12 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886785, encodeId=aee7886e8563, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200911/86e05ece1f2c4d5ab7a4a35c0243a1f3/895d564b15c340ebb73be808a4e3de8f.jpg, createdBy=50935306414, createdName=医学生upup木子楠, createdTime=Sun Sep 20 08:48:00 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884527, encodeId=0e2b88452ee7, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200911/86e05ece1f2c4d5ab7a4a35c0243a1f3/895d564b15c340ebb73be808a4e3de8f.jpg, createdBy=50935306414, createdName=医学生upup木子楠, createdTime=Fri Sep 11 13:27:06 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884526, encodeId=9c8e884526f6, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200911/86e05ece1f2c4d5ab7a4a35c0243a1f3/895d564b15c340ebb73be808a4e3de8f.jpg, createdBy=50935306414, createdName=医学生upup木子楠, createdTime=Fri Sep 11 13:26:34 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884410, encodeId=260f884410c8, content=学习。, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7572458878, createdName=12412355m93暂无昵称, createdTime=Fri Sep 11 05:36:23 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884367, encodeId=6cd688436e1f, content=继续与病魔抗争,希望有胜利的一天。, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Thu Sep 10 22:56:15 CST 2020, time=2020-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884249, encodeId=188688424982, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/a59b28b63198490ea85b1e5b3d13c2bf/1b1e0d03ca22467d8120443ebbc24c04.jpg, createdBy=35d22207591, createdName=120cac51m28暂无昵称, createdTime=Thu Sep 10 16:09:47 CST 2020, time=2020-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884248, encodeId=f63b884248a0, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/a59b28b63198490ea85b1e5b3d13c2bf/1b1e0d03ca22467d8120443ebbc24c04.jpg, createdBy=35d22207591, createdName=120cac51m28暂无昵称, createdTime=Thu Sep 10 15:55:50 CST 2020, time=2020-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035412, encodeId=602a1035412c5, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Sep 10 15:11:42 CST 2020, time=2020-09-10, status=1, ipAttribution=)]
    2020-09-20 医学生upup木子楠

    非常好的文章

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=887344, encodeId=e6ce88e344e6, content=谢谢分, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK0iclWFtP7WicKXLyVXAOnRibMria0BwB4otV2d2ibbbkZ2XKAvnNH5x3Y1wm9ibMNZZV5ib5qA0B99sMpw/132, createdBy=9a062530214, createdName=yelinlin, createdTime=Tue Sep 22 14:01:19 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886787, encodeId=65fb886e870e, content=非常好的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200911/86e05ece1f2c4d5ab7a4a35c0243a1f3/895d564b15c340ebb73be808a4e3de8f.jpg, createdBy=50935306414, createdName=医学生upup木子楠, createdTime=Sun Sep 20 08:58:12 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886785, encodeId=aee7886e8563, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200911/86e05ece1f2c4d5ab7a4a35c0243a1f3/895d564b15c340ebb73be808a4e3de8f.jpg, createdBy=50935306414, createdName=医学生upup木子楠, createdTime=Sun Sep 20 08:48:00 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884527, encodeId=0e2b88452ee7, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200911/86e05ece1f2c4d5ab7a4a35c0243a1f3/895d564b15c340ebb73be808a4e3de8f.jpg, createdBy=50935306414, createdName=医学生upup木子楠, createdTime=Fri Sep 11 13:27:06 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884526, encodeId=9c8e884526f6, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200911/86e05ece1f2c4d5ab7a4a35c0243a1f3/895d564b15c340ebb73be808a4e3de8f.jpg, createdBy=50935306414, createdName=医学生upup木子楠, createdTime=Fri Sep 11 13:26:34 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884410, encodeId=260f884410c8, content=学习。, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7572458878, createdName=12412355m93暂无昵称, createdTime=Fri Sep 11 05:36:23 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884367, encodeId=6cd688436e1f, content=继续与病魔抗争,希望有胜利的一天。, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Thu Sep 10 22:56:15 CST 2020, time=2020-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884249, encodeId=188688424982, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/a59b28b63198490ea85b1e5b3d13c2bf/1b1e0d03ca22467d8120443ebbc24c04.jpg, createdBy=35d22207591, createdName=120cac51m28暂无昵称, createdTime=Thu Sep 10 16:09:47 CST 2020, time=2020-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884248, encodeId=f63b884248a0, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/a59b28b63198490ea85b1e5b3d13c2bf/1b1e0d03ca22467d8120443ebbc24c04.jpg, createdBy=35d22207591, createdName=120cac51m28暂无昵称, createdTime=Thu Sep 10 15:55:50 CST 2020, time=2020-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035412, encodeId=602a1035412c5, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Sep 10 15:11:42 CST 2020, time=2020-09-10, status=1, ipAttribution=)]
    2020-09-20 医学生upup木子楠

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=887344, encodeId=e6ce88e344e6, content=谢谢分, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK0iclWFtP7WicKXLyVXAOnRibMria0BwB4otV2d2ibbbkZ2XKAvnNH5x3Y1wm9ibMNZZV5ib5qA0B99sMpw/132, createdBy=9a062530214, createdName=yelinlin, createdTime=Tue Sep 22 14:01:19 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886787, encodeId=65fb886e870e, content=非常好的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200911/86e05ece1f2c4d5ab7a4a35c0243a1f3/895d564b15c340ebb73be808a4e3de8f.jpg, createdBy=50935306414, createdName=医学生upup木子楠, createdTime=Sun Sep 20 08:58:12 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886785, encodeId=aee7886e8563, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200911/86e05ece1f2c4d5ab7a4a35c0243a1f3/895d564b15c340ebb73be808a4e3de8f.jpg, createdBy=50935306414, createdName=医学生upup木子楠, createdTime=Sun Sep 20 08:48:00 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884527, encodeId=0e2b88452ee7, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200911/86e05ece1f2c4d5ab7a4a35c0243a1f3/895d564b15c340ebb73be808a4e3de8f.jpg, createdBy=50935306414, createdName=医学生upup木子楠, createdTime=Fri Sep 11 13:27:06 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884526, encodeId=9c8e884526f6, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200911/86e05ece1f2c4d5ab7a4a35c0243a1f3/895d564b15c340ebb73be808a4e3de8f.jpg, createdBy=50935306414, createdName=医学生upup木子楠, createdTime=Fri Sep 11 13:26:34 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884410, encodeId=260f884410c8, content=学习。, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7572458878, createdName=12412355m93暂无昵称, createdTime=Fri Sep 11 05:36:23 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884367, encodeId=6cd688436e1f, content=继续与病魔抗争,希望有胜利的一天。, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Thu Sep 10 22:56:15 CST 2020, time=2020-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884249, encodeId=188688424982, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/a59b28b63198490ea85b1e5b3d13c2bf/1b1e0d03ca22467d8120443ebbc24c04.jpg, createdBy=35d22207591, createdName=120cac51m28暂无昵称, createdTime=Thu Sep 10 16:09:47 CST 2020, time=2020-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884248, encodeId=f63b884248a0, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/a59b28b63198490ea85b1e5b3d13c2bf/1b1e0d03ca22467d8120443ebbc24c04.jpg, createdBy=35d22207591, createdName=120cac51m28暂无昵称, createdTime=Thu Sep 10 15:55:50 CST 2020, time=2020-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035412, encodeId=602a1035412c5, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Sep 10 15:11:42 CST 2020, time=2020-09-10, status=1, ipAttribution=)]
    2020-09-11 医学生upup木子楠

    挺好的

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=887344, encodeId=e6ce88e344e6, content=谢谢分, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK0iclWFtP7WicKXLyVXAOnRibMria0BwB4otV2d2ibbbkZ2XKAvnNH5x3Y1wm9ibMNZZV5ib5qA0B99sMpw/132, createdBy=9a062530214, createdName=yelinlin, createdTime=Tue Sep 22 14:01:19 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886787, encodeId=65fb886e870e, content=非常好的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200911/86e05ece1f2c4d5ab7a4a35c0243a1f3/895d564b15c340ebb73be808a4e3de8f.jpg, createdBy=50935306414, createdName=医学生upup木子楠, createdTime=Sun Sep 20 08:58:12 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886785, encodeId=aee7886e8563, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200911/86e05ece1f2c4d5ab7a4a35c0243a1f3/895d564b15c340ebb73be808a4e3de8f.jpg, createdBy=50935306414, createdName=医学生upup木子楠, createdTime=Sun Sep 20 08:48:00 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884527, encodeId=0e2b88452ee7, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200911/86e05ece1f2c4d5ab7a4a35c0243a1f3/895d564b15c340ebb73be808a4e3de8f.jpg, createdBy=50935306414, createdName=医学生upup木子楠, createdTime=Fri Sep 11 13:27:06 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884526, encodeId=9c8e884526f6, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200911/86e05ece1f2c4d5ab7a4a35c0243a1f3/895d564b15c340ebb73be808a4e3de8f.jpg, createdBy=50935306414, createdName=医学生upup木子楠, createdTime=Fri Sep 11 13:26:34 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884410, encodeId=260f884410c8, content=学习。, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7572458878, createdName=12412355m93暂无昵称, createdTime=Fri Sep 11 05:36:23 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884367, encodeId=6cd688436e1f, content=继续与病魔抗争,希望有胜利的一天。, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Thu Sep 10 22:56:15 CST 2020, time=2020-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884249, encodeId=188688424982, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/a59b28b63198490ea85b1e5b3d13c2bf/1b1e0d03ca22467d8120443ebbc24c04.jpg, createdBy=35d22207591, createdName=120cac51m28暂无昵称, createdTime=Thu Sep 10 16:09:47 CST 2020, time=2020-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884248, encodeId=f63b884248a0, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/a59b28b63198490ea85b1e5b3d13c2bf/1b1e0d03ca22467d8120443ebbc24c04.jpg, createdBy=35d22207591, createdName=120cac51m28暂无昵称, createdTime=Thu Sep 10 15:55:50 CST 2020, time=2020-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035412, encodeId=602a1035412c5, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Sep 10 15:11:42 CST 2020, time=2020-09-10, status=1, ipAttribution=)]
    2020-09-11 医学生upup木子楠

    挺好的

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=887344, encodeId=e6ce88e344e6, content=谢谢分, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK0iclWFtP7WicKXLyVXAOnRibMria0BwB4otV2d2ibbbkZ2XKAvnNH5x3Y1wm9ibMNZZV5ib5qA0B99sMpw/132, createdBy=9a062530214, createdName=yelinlin, createdTime=Tue Sep 22 14:01:19 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886787, encodeId=65fb886e870e, content=非常好的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200911/86e05ece1f2c4d5ab7a4a35c0243a1f3/895d564b15c340ebb73be808a4e3de8f.jpg, createdBy=50935306414, createdName=医学生upup木子楠, createdTime=Sun Sep 20 08:58:12 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886785, encodeId=aee7886e8563, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200911/86e05ece1f2c4d5ab7a4a35c0243a1f3/895d564b15c340ebb73be808a4e3de8f.jpg, createdBy=50935306414, createdName=医学生upup木子楠, createdTime=Sun Sep 20 08:48:00 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884527, encodeId=0e2b88452ee7, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200911/86e05ece1f2c4d5ab7a4a35c0243a1f3/895d564b15c340ebb73be808a4e3de8f.jpg, createdBy=50935306414, createdName=医学生upup木子楠, createdTime=Fri Sep 11 13:27:06 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884526, encodeId=9c8e884526f6, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200911/86e05ece1f2c4d5ab7a4a35c0243a1f3/895d564b15c340ebb73be808a4e3de8f.jpg, createdBy=50935306414, createdName=医学生upup木子楠, createdTime=Fri Sep 11 13:26:34 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884410, encodeId=260f884410c8, content=学习。, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7572458878, createdName=12412355m93暂无昵称, createdTime=Fri Sep 11 05:36:23 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884367, encodeId=6cd688436e1f, content=继续与病魔抗争,希望有胜利的一天。, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Thu Sep 10 22:56:15 CST 2020, time=2020-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884249, encodeId=188688424982, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/a59b28b63198490ea85b1e5b3d13c2bf/1b1e0d03ca22467d8120443ebbc24c04.jpg, createdBy=35d22207591, createdName=120cac51m28暂无昵称, createdTime=Thu Sep 10 16:09:47 CST 2020, time=2020-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884248, encodeId=f63b884248a0, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/a59b28b63198490ea85b1e5b3d13c2bf/1b1e0d03ca22467d8120443ebbc24c04.jpg, createdBy=35d22207591, createdName=120cac51m28暂无昵称, createdTime=Thu Sep 10 15:55:50 CST 2020, time=2020-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035412, encodeId=602a1035412c5, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Sep 10 15:11:42 CST 2020, time=2020-09-10, status=1, ipAttribution=)]
    2020-09-11 12412355m93暂无昵称

    学习。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=887344, encodeId=e6ce88e344e6, content=谢谢分, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK0iclWFtP7WicKXLyVXAOnRibMria0BwB4otV2d2ibbbkZ2XKAvnNH5x3Y1wm9ibMNZZV5ib5qA0B99sMpw/132, createdBy=9a062530214, createdName=yelinlin, createdTime=Tue Sep 22 14:01:19 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886787, encodeId=65fb886e870e, content=非常好的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200911/86e05ece1f2c4d5ab7a4a35c0243a1f3/895d564b15c340ebb73be808a4e3de8f.jpg, createdBy=50935306414, createdName=医学生upup木子楠, createdTime=Sun Sep 20 08:58:12 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886785, encodeId=aee7886e8563, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200911/86e05ece1f2c4d5ab7a4a35c0243a1f3/895d564b15c340ebb73be808a4e3de8f.jpg, createdBy=50935306414, createdName=医学生upup木子楠, createdTime=Sun Sep 20 08:48:00 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884527, encodeId=0e2b88452ee7, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200911/86e05ece1f2c4d5ab7a4a35c0243a1f3/895d564b15c340ebb73be808a4e3de8f.jpg, createdBy=50935306414, createdName=医学生upup木子楠, createdTime=Fri Sep 11 13:27:06 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884526, encodeId=9c8e884526f6, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200911/86e05ece1f2c4d5ab7a4a35c0243a1f3/895d564b15c340ebb73be808a4e3de8f.jpg, createdBy=50935306414, createdName=医学生upup木子楠, createdTime=Fri Sep 11 13:26:34 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884410, encodeId=260f884410c8, content=学习。, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7572458878, createdName=12412355m93暂无昵称, createdTime=Fri Sep 11 05:36:23 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884367, encodeId=6cd688436e1f, content=继续与病魔抗争,希望有胜利的一天。, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Thu Sep 10 22:56:15 CST 2020, time=2020-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884249, encodeId=188688424982, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/a59b28b63198490ea85b1e5b3d13c2bf/1b1e0d03ca22467d8120443ebbc24c04.jpg, createdBy=35d22207591, createdName=120cac51m28暂无昵称, createdTime=Thu Sep 10 16:09:47 CST 2020, time=2020-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884248, encodeId=f63b884248a0, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/a59b28b63198490ea85b1e5b3d13c2bf/1b1e0d03ca22467d8120443ebbc24c04.jpg, createdBy=35d22207591, createdName=120cac51m28暂无昵称, createdTime=Thu Sep 10 15:55:50 CST 2020, time=2020-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035412, encodeId=602a1035412c5, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Sep 10 15:11:42 CST 2020, time=2020-09-10, status=1, ipAttribution=)]
    2020-09-10 言西早

    继续与病魔抗争,希望有胜利的一天。

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=887344, encodeId=e6ce88e344e6, content=谢谢分, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK0iclWFtP7WicKXLyVXAOnRibMria0BwB4otV2d2ibbbkZ2XKAvnNH5x3Y1wm9ibMNZZV5ib5qA0B99sMpw/132, createdBy=9a062530214, createdName=yelinlin, createdTime=Tue Sep 22 14:01:19 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886787, encodeId=65fb886e870e, content=非常好的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200911/86e05ece1f2c4d5ab7a4a35c0243a1f3/895d564b15c340ebb73be808a4e3de8f.jpg, createdBy=50935306414, createdName=医学生upup木子楠, createdTime=Sun Sep 20 08:58:12 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886785, encodeId=aee7886e8563, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200911/86e05ece1f2c4d5ab7a4a35c0243a1f3/895d564b15c340ebb73be808a4e3de8f.jpg, createdBy=50935306414, createdName=医学生upup木子楠, createdTime=Sun Sep 20 08:48:00 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884527, encodeId=0e2b88452ee7, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200911/86e05ece1f2c4d5ab7a4a35c0243a1f3/895d564b15c340ebb73be808a4e3de8f.jpg, createdBy=50935306414, createdName=医学生upup木子楠, createdTime=Fri Sep 11 13:27:06 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884526, encodeId=9c8e884526f6, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200911/86e05ece1f2c4d5ab7a4a35c0243a1f3/895d564b15c340ebb73be808a4e3de8f.jpg, createdBy=50935306414, createdName=医学生upup木子楠, createdTime=Fri Sep 11 13:26:34 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884410, encodeId=260f884410c8, content=学习。, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7572458878, createdName=12412355m93暂无昵称, createdTime=Fri Sep 11 05:36:23 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884367, encodeId=6cd688436e1f, content=继续与病魔抗争,希望有胜利的一天。, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Thu Sep 10 22:56:15 CST 2020, time=2020-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884249, encodeId=188688424982, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/a59b28b63198490ea85b1e5b3d13c2bf/1b1e0d03ca22467d8120443ebbc24c04.jpg, createdBy=35d22207591, createdName=120cac51m28暂无昵称, createdTime=Thu Sep 10 16:09:47 CST 2020, time=2020-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884248, encodeId=f63b884248a0, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/a59b28b63198490ea85b1e5b3d13c2bf/1b1e0d03ca22467d8120443ebbc24c04.jpg, createdBy=35d22207591, createdName=120cac51m28暂无昵称, createdTime=Thu Sep 10 15:55:50 CST 2020, time=2020-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035412, encodeId=602a1035412c5, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Sep 10 15:11:42 CST 2020, time=2020-09-10, status=1, ipAttribution=)]
    2020-09-10 120cac51m28暂无昵称

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=887344, encodeId=e6ce88e344e6, content=谢谢分, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK0iclWFtP7WicKXLyVXAOnRibMria0BwB4otV2d2ibbbkZ2XKAvnNH5x3Y1wm9ibMNZZV5ib5qA0B99sMpw/132, createdBy=9a062530214, createdName=yelinlin, createdTime=Tue Sep 22 14:01:19 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886787, encodeId=65fb886e870e, content=非常好的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200911/86e05ece1f2c4d5ab7a4a35c0243a1f3/895d564b15c340ebb73be808a4e3de8f.jpg, createdBy=50935306414, createdName=医学生upup木子楠, createdTime=Sun Sep 20 08:58:12 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886785, encodeId=aee7886e8563, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200911/86e05ece1f2c4d5ab7a4a35c0243a1f3/895d564b15c340ebb73be808a4e3de8f.jpg, createdBy=50935306414, createdName=医学生upup木子楠, createdTime=Sun Sep 20 08:48:00 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884527, encodeId=0e2b88452ee7, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200911/86e05ece1f2c4d5ab7a4a35c0243a1f3/895d564b15c340ebb73be808a4e3de8f.jpg, createdBy=50935306414, createdName=医学生upup木子楠, createdTime=Fri Sep 11 13:27:06 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884526, encodeId=9c8e884526f6, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200911/86e05ece1f2c4d5ab7a4a35c0243a1f3/895d564b15c340ebb73be808a4e3de8f.jpg, createdBy=50935306414, createdName=医学生upup木子楠, createdTime=Fri Sep 11 13:26:34 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884410, encodeId=260f884410c8, content=学习。, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7572458878, createdName=12412355m93暂无昵称, createdTime=Fri Sep 11 05:36:23 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884367, encodeId=6cd688436e1f, content=继续与病魔抗争,希望有胜利的一天。, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Thu Sep 10 22:56:15 CST 2020, time=2020-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884249, encodeId=188688424982, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/a59b28b63198490ea85b1e5b3d13c2bf/1b1e0d03ca22467d8120443ebbc24c04.jpg, createdBy=35d22207591, createdName=120cac51m28暂无昵称, createdTime=Thu Sep 10 16:09:47 CST 2020, time=2020-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884248, encodeId=f63b884248a0, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/a59b28b63198490ea85b1e5b3d13c2bf/1b1e0d03ca22467d8120443ebbc24c04.jpg, createdBy=35d22207591, createdName=120cac51m28暂无昵称, createdTime=Thu Sep 10 15:55:50 CST 2020, time=2020-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035412, encodeId=602a1035412c5, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Sep 10 15:11:42 CST 2020, time=2020-09-10, status=1, ipAttribution=)]
    2020-09-10 120cac51m28暂无昵称

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=887344, encodeId=e6ce88e344e6, content=谢谢分, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK0iclWFtP7WicKXLyVXAOnRibMria0BwB4otV2d2ibbbkZ2XKAvnNH5x3Y1wm9ibMNZZV5ib5qA0B99sMpw/132, createdBy=9a062530214, createdName=yelinlin, createdTime=Tue Sep 22 14:01:19 CST 2020, time=2020-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886787, encodeId=65fb886e870e, content=非常好的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200911/86e05ece1f2c4d5ab7a4a35c0243a1f3/895d564b15c340ebb73be808a4e3de8f.jpg, createdBy=50935306414, createdName=医学生upup木子楠, createdTime=Sun Sep 20 08:58:12 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886785, encodeId=aee7886e8563, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200911/86e05ece1f2c4d5ab7a4a35c0243a1f3/895d564b15c340ebb73be808a4e3de8f.jpg, createdBy=50935306414, createdName=医学生upup木子楠, createdTime=Sun Sep 20 08:48:00 CST 2020, time=2020-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884527, encodeId=0e2b88452ee7, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200911/86e05ece1f2c4d5ab7a4a35c0243a1f3/895d564b15c340ebb73be808a4e3de8f.jpg, createdBy=50935306414, createdName=医学生upup木子楠, createdTime=Fri Sep 11 13:27:06 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884526, encodeId=9c8e884526f6, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200911/86e05ece1f2c4d5ab7a4a35c0243a1f3/895d564b15c340ebb73be808a4e3de8f.jpg, createdBy=50935306414, createdName=医学生upup木子楠, createdTime=Fri Sep 11 13:26:34 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884410, encodeId=260f884410c8, content=学习。, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7572458878, createdName=12412355m93暂无昵称, createdTime=Fri Sep 11 05:36:23 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884367, encodeId=6cd688436e1f, content=继续与病魔抗争,希望有胜利的一天。, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Thu Sep 10 22:56:15 CST 2020, time=2020-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884249, encodeId=188688424982, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/a59b28b63198490ea85b1e5b3d13c2bf/1b1e0d03ca22467d8120443ebbc24c04.jpg, createdBy=35d22207591, createdName=120cac51m28暂无昵称, createdTime=Thu Sep 10 16:09:47 CST 2020, time=2020-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884248, encodeId=f63b884248a0, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201117/a59b28b63198490ea85b1e5b3d13c2bf/1b1e0d03ca22467d8120443ebbc24c04.jpg, createdBy=35d22207591, createdName=120cac51m28暂无昵称, createdTime=Thu Sep 10 15:55:50 CST 2020, time=2020-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035412, encodeId=602a1035412c5, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Sep 10 15:11:42 CST 2020, time=2020-09-10, status=1, ipAttribution=)]
    2020-09-10 旺医

    顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息

    0

相关资讯

NEJM:新型隐球菌脑膜脑炎-病例报道

该患者开始用脂质体两性霉素B和氟胞嘧啶诱导治疗,并且在治疗2周后注意到症状的消退和CSF培养结果阴性。该患者开始采用氟康唑进行巩固治疗,后来开了抗逆转录病毒疗法。

Baidu
map
Baidu
map
Baidu
map